You searched for "Gene therapy"
Outcomes of plaque radiotherapy for retinoblastoma
3 April 2023
| Fiona Rowe (Prof)
|
Paediatric Ophthalmology / Strabismus
The study authors evaluate their experience of plaque radiotherapy for retinoblastoma (RB) in 41 eyes of 41 patients that failed intra-arterial chemotherapy (IAC). This was a retrospective review including 21 females and 20 males. Median age was 18 months and...
Medical treatment of orbital lymphatic malformations
5 August 2020
| James Hsuan
|
Paediatric Ophthalmology / Strabismus
This is a literature review of the use of Sirolimus, to treat orbital lymphatic malformations. Sirolimus is an immunosuppressant used in renal transplants, and acts by inhibiting mammalian target of rapamycin (mTOR), which in turn inhibits activation of T and...
Development of retinoblastoma care in Indonesia and the role of multidisciplinary team meetings
4 August 2021
| Primawita Oktarima (Dr), Mayasari Wahyu Kuntorini (Dr), Anne Susanty (Dr), Andi Pratiwi (Dr), Anna Radwanska (Dr), Marlyanti Nur Rahmah (Dr), Marcia Zondervan
|
EYE - Paediatrics, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
In the second article of a two-part series (See Part 1 here), the authors focus on the diagnosis and management of retinoblastoma in Indonesia. COVID-19 doesn’t get thanked for many things, but on 19 December 2020 as the world grew...
Long-term outcomes for hereditary retinoblastoma
1 December 2014
| Nana Theodorou
|
Paediatric Ophthalmology / Strabismus
|
chemotherapy, failure rate, focal therapy, hereditary retinoblastoma, visual acuity
Earlier diagnosis and more rigorous treatment regimens have contributed to better outcomes for patients with retinoblastoma. This study looked at 24 patients with hereditary bilateral retinoblastoma treated with systemic chemotherapy during a ten year period (2001-2011). The medical notes were...
Systemic rituximab immunotherapy in the management of primary ocular adnexal lymphoma single institutional experience
Ocular adnexal lymphomas constitute 2% of all non-Hodgkin’s disease and 5-15% of all extranodal lymphomas and are usually localised, low-grade and of B-cell origin. This opens them up to potential treatment with a systemic monoclonal antibody-based drug (rituximab) directed at...Use of Leflunomide as a treatment for paediatric chronic uveitis
2 August 2024
| Fiona Rowe (Prof)
|
Paediatric Ophthalmology / Strabismus
Leflunomide is a disease modifying anti-rheumatic drug approved for treatment of rheumatoid arthritis and psoriatic arthritis in adult patients. This study reports five illustrative case reports of children using Leflunomide as an adjunct treatment with anti-tumour necrosis factor (TNF) agents...
Microbiology, risk factors and outcomes of microbial keratitis in Sydney, Australia
5 February 2020
| Kurt Spiteri Cornish
|
EYE - Cornea, EYE - General
|
Microbial keratitis, cornea, dry eye, keratitis, ocular surface disease
The authors present a retrospective case series including all patients with microbial keratitis and ocular surface diseases (OSD), including dry eye, blepharitis, Stevens-Johnson syndrome and / or ocular cicatricial pemphigoid, over a five-year period between 2012 and 2016. A total...
Lacrimal drainage system malignancies
This retrospective case series looks at the rare cases of lacrimal drainage system malignancies. The authors have identified 14 patients in 24 years, at a tertiary referral centre in the Indian subcontinent. Many previous publications have found squamous cell carcinoma...Outcomes of chemo versus no therapy for optic pathway glioma in NF1
3 February 2023
| Fiona Rowe (Prof)
|
Paediatric Ophthalmology / Strabismus
The aim of this study was to evaluate the visual outcomes of a cohort of children with optic pathway gliomas and neurofibromatosis type 1 (NF1), with comparison of children treated with chemotherapy or not. This was a retrospective study of...
Lacrimal gland carcinoma outcomes
1 April 2019
| James Hsuan
|
EYE - Oculoplastic
This is retrospective review of outcomes of lacrimal gland epithelial tumours treated between 1972 and 2014 at Moorfields Eye Hospital. Seventy-nine patients were reported, comprising 53 adenoid cystic carcinomas, 15 primary adenocarcinomas and 11 carcinomas ex-pleomorphic adenoma. The authors compare...
Melphalon treatment of retinoblastoma
1 October 2014
| Fiona Rowe (Prof)
|
Paediatric Ophthalmology / Strabismus
The purpose of this study was to report the authors’ experience with superselective ophthalmic artery infusion of Melphalon (SOAIM) for the treatment of five cases of unilateral sporadic retinoblastoma involving the macula. Standard therapy included a cycle of three infusions...